EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Exosomal Non‐Coding RNAs in Gastrointestinal Cancer Drug Resistance: A Systematic Review of Emerging Mechanisms and Clinical Implications

Mohsen Sharif-Zak iD, Zahra Sadeghloo, Fateme Binayi, Stefania Nobili, Sara Ashtari iD, Amir Sadeghi iD, Nayeralsadat Fatemi iD

Journal of Cellular and Molecular Medicine · 2026-05 · 30 (9)

DOI: 10.1111/jcmm.71137 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 08.05.2026. Verfasst von Mohsen Sharif-Zak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medica…. Hauptthemen laut MEDLINE: Exosomes, Drug Resistance, Neoplasm, Gastrointestinal Neoplasms, RNA, Untranslated. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) tumours are one of the most prevalent cancers globally. Even with normal GI function, individuals may develop neoplasms, highlighting the need to better understand the underlying causes of tumorigenesis. The emergence of tumour drug resistance represents the main reason for the failure of drug treatment; thus, it is imperative to investigate all the potential mechanisms of this very complex phenomenon. It is significant that exosomes and noncoding RNAs, such as microRNAs (miRNAs), long non‐coding RNAs (lncRNAs) and circular RNAs (circRNAs), originating from tumour cells, are linked to both GI drug resistance and the carcinogenesis and development of GI disease. Thus, we propose a systematic review of the literature to provide an overview of the current landscape concerning exosomal ncRNAs as diagnostic and prognostic biomarker resources in resistant GI cancer. We performed the current systematic review according to PRISMA guidelines and comprehensively explored PubMed, Web of Science, Scopus and Google Scholar databases to achieve the article search. Seventy‐six studies were included in the investigation, comprising 50 cohort studies and 26 nested case–control studies (between 1994 and 2025). Among all systematically reviewed exosomal ncRNAs, we primarily found molecules with prognostic significance and predictive relevance, and those that serve both purposes have been identified. Furthermore, among all analysed ncRNAs isolated from exosomes, miRNAs, lncRNAs and circRNAs have emerged as the most extensively studied and are proposed as potential tools for predicting resistance or sensitivity to GI cancer treatments. Our analysis offers a comprehensive overview of the current landscape concerning exosomal ncRNAs as potential clinical biomarkers for resistant GI tumours. However, despite extensive research efforts, the application of exosomal biomarkers in GI cancers is still in its infancy. None of the identified exosomal biomarkers have advanced beyond preclinical studies, and their applicability in clinical settings remains limited, largely due to challenges in clinical validation, standardisation and biomarker specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesDrug Resistance, NeoplasmGastrointestinal NeoplasmsRNA, UntranslatedHumansBiomarkers, TumorMicroRNAsPrognosisGene Expression Regulation, NeoplasticAnimalsRNA, Long NoncodingRNA, Circular

Stichwörter der Autor:innen

RNAdrug resistanceexosomesgastrointestinal neoplasmsneoplasmuntranslated

Substanzen

Biomarkers, TumorRNA, UntranslatedMicroRNAsRNA, Long NoncodingRNA, Circular

Autor:innen und Institutionen

  • Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Firenze, Italy.

ORCID-Profile: Mohsen Sharif-Zak, Sara Ashtari, Amir Sadeghi, Nayeralsadat Fatemi

Zitieren

APA

Sharif-Zak, M., Sadeghloo, Z., Binayi, F., Nobili, S., Ashtari, S., Sadeghi, A., & Fatemi, N. (2026). Exosomal Non‐Coding RNAs in Gastrointestinal Cancer Drug Resistance: A Systematic Review of Emerging Mechanisms and Clinical Implications. Journal of Cellular and Molecular Medicine, 30(9). https://doi.org/10.1111/jcmm.71137

Vancouver

Sharif-Zak M, Sadeghloo Z, Binayi F, Nobili S, Ashtari S, Sadeghi A, et al. Exosomal Non‐Coding RNAs in Gastrointestinal Cancer Drug Resistance: A Systematic Review of Emerging Mechanisms and Clinical Implications. Journal of Cellular and Molecular Medicine. 2026;30(9). doi:10.1111/jcmm.71137

BibTeX
@article{SharifZak2026,
  author = {Sharif-Zak, Mohsen and Sadeghloo, Zahra and Binayi, Fateme and Nobili, Stefania and Ashtari, Sara and Sadeghi, Amir and Fatemi, Nayeralsadat},
  title = {Exosomal Non‐Coding RNAs in Gastrointestinal Cancer Drug Resistance: A Systematic Review of Emerging Mechanisms and Clinical Implications},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {9},
  doi = {10.1111/jcmm.71137}
}
Kostenlos starten →